Get Level 2

Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. PureTech Share Price
  4. PureTech Share Regulatory News
  5. Transaction in Own Shares

Pin to quick picksPureTech Regulatory News (PRTC)

PureTech Information

Share Price Information for PureTech (PRTC)

Share Price is delayed by 15 minutes
Get Live Data
131.20    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.40 (0.306%)
Market Cap: £319.36m
PRTC Live PriceLast checked at - London Stock Exchange

Intraday PureTech Share Chart

Transaction in Own Shares

26 Oct 2023 07:00

RNS Number : 3169R
PureTech Health PLC
26 October 2023
 

26 October 2023

 

PureTech Health plc

 

Transaction in Own Shares

 

PureTech Health PLC (the "Company") announces that it has purchased the following number of its ordinary shares of one pence each through Jefferies International Limited ("Jefferies"), as part of its Share Buyback Programme, details of which were announced on 9 May 2022.

 

Date of purchase:

25 October 2023

Number of ordinary shares purchased:

38,361

Highest price paid per share:

169.40p

Lowest price paid per share:

163.40p

Volume weighted average price paid per share:

166.20p

 

PureTech intends to retain the purchased shares in treasury.

Following the above transaction, the Company will have 15,789,236 ordinary shares in treasury and has 273,678,923 ordinary shares in issue (excluding treasury shares). The total number of voting rights in the Company is therefore 273,678,923 which may be used by shareholders in their calculations to determine if they are required to notify their interest in, or a change to their interest in, PureTech Health plc under the FCA's Disclosure Guidance and Transparency Rules.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation), detailed information about the individual purchases is available below.

 

About PureTech Health

PureTech is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad and deep pipeline through its experienced research and development team and its extensive network of scientists, clinicians and industry leaders that is being advanced both internally and through its Founded Entities. PureTech's R&D engine has resulted in the development of 27 therapeutics and therapeutic candidates, including two (Plenity® and EndeavorRx®) that have received both U.S. FDA clearance and European marketing authorization and a third (KarXT) that has been filed for FDA approval. A number of these programs are being advanced by PureTech or its Founded Entities in various indications and stages of clinical development, including registration enabling studies. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points.

 

For more information, visit www.puretechhealth.com or connect with us on X, formerly known as Twitter, @puretechh.

 

Contact:

PureTech

Investor Relations

IR@puretechhealth.com

Individual Transactions

 

Transaction Date

Transaction Time

Volume

Price (GBp)

Platform

Transaction Reference Number

25/10/2023

14:01:04

227

169.4

XLON

00375333087TRLO0.1.1

25/10/2023

14:01:04

13

169.4

XLON

00375333088TRLO0.1.1

25/10/2023

14:01:04

239

169.4

XLON

00375333089TRLO0.1.1

25/10/2023

14:01:04

2107

169.4

XLON

00375333090TRLO0.1.1

25/10/2023

14:01:30

180

169.4

XLON

00375333166TRLO0.1.1

25/10/2023

14:02:48

907

166.6

XLON

00375333349TRLO0.1.1

25/10/2023

14:02:48

572

166.6

XLON

00375333348TRLO0.1.1

25/10/2023

14:02:53

228

168.2

XLON

00375333355TRLO0.1.1

25/10/2023

14:02:58

176

168.8

XLON

00375333366TRLO0.1.1

25/10/2023

14:02:58

210

168.8

XLON

00375333365TRLO0.1.1

25/10/2023

14:03:01

615

168.6

XLON

00375333388TRLO0.1.1

25/10/2023

14:03:01

503

168.8

XLON

00375333389TRLO0.1.1

25/10/2023

14:04:36

509

168.8

XLON

00375333666TRLO0.1.1

25/10/2023

14:07:34

998

168.8

XLON

00375334120TRLO0.1.1

25/10/2023

14:07:38

499

168.8

XLON

00375334137TRLO0.1.1

25/10/2023

14:07:44

499

168.8

XLON

00375334174TRLO0.1.1

25/10/2023

14:07:49

235

168.8

XLON

00375334180TRLO0.1.1

25/10/2023

14:07:49

499

168.8

XLON

00375334181TRLO0.1.1

25/10/2023

14:07:55

26

168.6

XLON

00375334212TRLO0.1.1

25/10/2023

14:07:55

499

168.6

XLON

00375334213TRLO0.1.1

25/10/2023

14:08:39

499

168.6

XLON

00375334332TRLO0.1.1

25/10/2023

14:08:41

564

168.6

XLON

00375334367TRLO0.1.1

25/10/2023

14:08:41

499

168.6

XLON

00375334368TRLO0.1.1

25/10/2023

14:14:44

498

169

XLON

00375335145TRLO0.1.1

25/10/2023

14:32:51

197

168.8

AQXE

00375341505TRLO0.1.1

25/10/2023

14:32:53

730

168.6

XLON

00375341525TRLO0.1.1

25/10/2023

14:32:54

30

168.6

XLON

00375341537TRLO0.1.1

25/10/2023

14:32:54

610

168.6

XLON

00375341539TRLO0.1.1

25/10/2023

14:32:56

109

168.6

XLON

00375341549TRLO0.1.1

25/10/2023

14:32:59

168

168.2

CHIX

00375341564TRLO0.1.1

25/10/2023

14:33:05

270

168.2

CHIX

00375341607TRLO0.1.1

25/10/2023

14:33:07

22

168.2

CHIX

00375341613TRLO0.1.1

25/10/2023

14:33:26

94

167.8

TRQX

00375341845TRLO0.1.1

25/10/2023

14:33:26

413

167.4

BATE

00375341846TRLO0.1.1

25/10/2023

14:34:19

1722

166.8

XLON

00375342302TRLO0.1.1

25/10/2023

14:35:59

558

166.8

XLON

00375343418TRLO0.1.1

25/10/2023

14:37:03

22

165.4

XLON

00375343925TRLO0.1.1

25/10/2023

14:37:05

11

166

AQXE

00375343956TRLO0.1.1

25/10/2023

14:38:06

471

165.4

XLON

00375344425TRLO0.1.1

25/10/2023

14:38:06

1479

165.4

XLON

00375344426TRLO0.1.1

25/10/2023

14:38:11

974

165.4

AQXE

00375344457TRLO0.1.1

25/10/2023

14:46:29

197

165.4

AQXE

00375350573TRLO0.1.1

25/10/2023

14:46:30

32

165.6

TRQX

00375350586TRLO0.1.1

25/10/2023

14:46:34

32

165.6

BATE

00375350635TRLO0.1.1

25/10/2023

14:47:50

500

165.6

XLON

00375352074TRLO0.1.1

25/10/2023

14:52:07

460

165.2

CHIX

00375354226TRLO0.1.1

25/10/2023

14:52:07

267

165.2

XLON

00375354227TRLO0.1.1

25/10/2023

14:52:07

50

165.2

XLON

00375354228TRLO0.1.1

25/10/2023

14:52:07

1162

165.2

XLON

00375354229TRLO0.1.1

25/10/2023

14:52:07

196

165

BATE

00375354230TRLO0.1.1

25/10/2023

14:52:07

191

165

BATE

00375354231TRLO0.1.1

25/10/2023

14:52:07

262

164.8

XLON

00375354233TRLO0.1.1

25/10/2023

14:52:07

26

165

BATE

00375354232TRLO0.1.1

25/10/2023

14:52:07

8

164.8

XLON

00375354234TRLO0.1.1

25/10/2023

14:52:07

223

164.8

XLON

00375354235TRLO0.1.1

25/10/2023

14:52:30

507

165.2

XLON

00375354372TRLO0.1.1

25/10/2023

14:52:30

498

165.2

XLON

00375354373TRLO0.1.1

25/10/2023

15:00:54

186

165

XLON

00375357706TRLO0.1.1

25/10/2023

15:01:10

180

165

XLON

00375357854TRLO0.1.1

25/10/2023

15:01:10

188

165

TRQX

00375357855TRLO0.1.1

25/10/2023

15:01:10

650

165

XLON

00375357856TRLO0.1.1

25/10/2023

15:01:10

463

165

XLON

00375357857TRLO0.1.1

25/10/2023

15:10:05

94

164.8

TRQX

00375360743TRLO0.1.1

25/10/2023

15:11:05

545

164.6

XLON

00375360996TRLO0.1.1

25/10/2023

15:11:05

441

164.6

XLON

00375360997TRLO0.1.1

25/10/2023

15:11:54

380

164.4

CHIX

00375361143TRLO0.1.1

25/10/2023

15:11:54

1000

164.4

CHIX

00375361142TRLO0.1.1

25/10/2023

15:11:54

460

164.4

CHIX

00375361144TRLO0.1.1

25/10/2023

15:11:54

493

164.4

XLON

00375361145TRLO0.1.1

25/10/2023

15:11:54

413

164.2

BATE

00375361154TRLO0.1.1

25/10/2023

15:11:54

1324

164.2

XLON

00375361156TRLO0.1.1

25/10/2023

15:11:54

155

164.2

XLON

00375361155TRLO0.1.1

25/10/2023

15:11:54

197

164

AQXE

00375361157TRLO0.1.1

25/10/2023

15:12:39

250

164.8

TRQX

00375361377TRLO0.1.1

25/10/2023

15:24:42

628

164

BATE

00375365152TRLO0.1.1

25/10/2023

15:27:55

232

164.2

XLON

00375366134TRLO0.1.1

25/10/2023

15:28:46

110

164.4

XLON

00375366324TRLO0.1.1

25/10/2023

15:37:01

1578

164

XLON

00375368628TRLO0.1.1

25/10/2023

15:43:17

302

163.4

CHIX

00375370662TRLO0.1.1

25/10/2023

15:46:51

94

164.2

TRQX

00375372210TRLO0.1.1

25/10/2023

16:04:58

10

163.4

CHIX

00375380483TRLO0.1.1

25/10/2023

16:09:20

8

164.2

TRQX

00375382696TRLO0.1.1

25/10/2023

16:10:45

86

164.2

TRQX

00375383351TRLO0.1.1

25/10/2023

16:12:38

325

163.8

XLON

00375384239TRLO0.1.1

25/10/2023

16:12:38

1071

163.8

XLON

00375384238TRLO0.1.1

25/10/2023

16:12:38

83

163.8

XLON

00375384240TRLO0.1.1

25/10/2023

16:13:42

10

163.6

CHIX

00375385006TRLO0.1.1

25/10/2023

16:14:46

10

163.6

CHIX

00375385530TRLO0.1.1

25/10/2023

16:15:36

2

163.6

CHIX

00375386206TRLO0.1.1

25/10/2023

16:20:29

10

163.6

BATE

00375389330TRLO0.1.1

25/10/2023

16:20:42

105

163.6

CHIX

00375389461TRLO0.1.1

25/10/2023

16:23:09

195

163.6

BATE

00375391196TRLO0.1.1

25/10/2023

16:23:09

11

163.6

BATE

00375391197TRLO0.1.1

25/10/2023

16:23:16

197

164

AQXE

00375391240TRLO0.1.1

25/10/2023

16:25:14

117

163.6

BATE

00375392492TRLO0.1.1

25/10/2023

16:25:14

80

163.6

BATE

00375392491TRLO0.1.1

25/10/2023

16:25:14

216

163.6

BATE

00375392493TRLO0.1.1

25/10/2023

16:25:39

140

163.4

XLON

00375392713TRLO0.1.1

25/10/2023

16:25:45

600

163.4

XLON

00375392758TRLO0.1.1

25/10/2023

16:25:45

72

163.4

XLON

00375392759TRLO0.1.1

25/10/2023

16:29:00

6

163.8

AQXE

00375394760TRLO0.1.1

25/10/2023

16:29:38

8

164.2

TRQX

00375395076TRLO0.1.1

25/10/2023

16:29:41

86

164.2

TRQX

00375395121TRLO0.1.1

25/10/2023

16:29:55

258

163.6

CHIX

00375395306TRLO0.1.1

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFLFIDIRLEFIV
12345678910
Date   Source Headline
10th Jun 20265:38 pmRNSResult of AGM
9th Jun 20267:00 amRNS-RPRTC's SPTX: New Positive GlyphAgo Ph1 Dosing Data
4th Jun 20265:37 pmRNSHolding(s) in Company
29th May 20265:00 pmRNSHolding(s) in Company
27th May 20265:30 pmRNSHolding(s) in Company
22nd May 20265:00 pmRNSHolding(s) in Company
15th May 20267:00 amRNSCorrection - Holding(s) in Company
13th May 202612:00 pmRNS-RPRTC To Showcase Deupirfenidone at ATS Conference
8th May 20267:00 amRNSHolding(s) in Company
7th May 20266:27 pmRNSHolding(s) in Company
1st May 20267:00 amRNSPureTech's Seaport Prices Upsized IPO Nasdaq: SPTX
29th Apr 20267:01 amRNSFinal Results
29th Apr 20267:00 amRNSPRTC Voluntarily Delists Nasdaq Depositary Shares
27th Apr 20266:09 pmRNSHolding(s) in Company
27th Apr 202612:05 pmRNS-RPRTC's Seaport Adds Neuropsychiatry Veteran to BOD
24th Apr 20265:58 pmRNSHolding(s) in Company
22nd Apr 202612:00 pmRNS-RPRTC's Gallop: Positive Ph1 Topline MDS & AML Data
16th Apr 20265:00 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSHolding(s) in Company
13th Apr 20267:05 amRNSNotice of Results
13th Apr 20267:00 amRNSPRTC's Seaport Files for Proposed Nasdaq IPO
1st Apr 20267:00 amRNSTotal Voting Rights
25th Mar 20266:00 pmRNS-RPRTC’s Seaport: GlyphAllo Paper Published
13th Mar 20264:35 pmRNSPDMR Notification RSU Vesting
2nd Mar 20267:00 amRNSTotal Voting Rights
25th Feb 20267:00 amRNS-RPRTC to Present at Leerink Healthcare Conference
19th Feb 20265:15 pmRNS-RPRTC's Deupirfenidone Granted FDA & EU ODD for IPF
6th Jan 202612:00 pmRNS-RPureTech to Present at the JP Morgan Conference
18th Dec 20257:00 amRNSPureTech Appoints Robert Lyne as CEO
10th Dec 20255:41 pmRNSResults of AGM on June 16, 2025 – Update Statement
10th Dec 20255:30 pmRNSHolding(s) in Company
8th Dec 20257:00 amRNS-RPRTC: Successful FDA Meeting; IPF Phase 3 in 1H26
5th Dec 20256:00 pmRNS-RPRTC's Gallop: Positive Initial Topline AML Data
18th Nov 20255:30 pmRNSHolding(s) in Company
7th Nov 20256:18 pmRNSHolding(s) in Company
3rd Nov 20252:00 pmRNS-RPRTC: New LYT-200 AML Data + Update at ASH
22nd Oct 20257:00 amRNS-RPRTC: New IPF Data Show Benefit in Older Patients
17th Oct 20255:30 pmRNSHolding(s) in Company
14th Oct 20257:00 amRNSHolding(s) in Company
10th Oct 20255:59 pmRNSHolding(s) in Company
9th Oct 20256:10 pmRNSHolding(s) in Company
1st Oct 20257:00 amRNSHolding(s) in Company
29th Sep 20257:00 amRNS-RPRTC: New IPF Data Show Switch Patients Stabilized
24th Sep 20257:00 amRNSPDMR DEALING - PURCHASE OF SHARES
23rd Sep 20255:30 pmRNSHolding(s) in Company
19th Sep 20255:52 pmRNSHolding(s) in Company
19th Sep 20257:00 amRNSHolding(s) in Company
11th Sep 202512:05 pmRNS-RPRTC's Seaport Advances 2nd Candidate Into Clinic
4th Sep 20255:30 pmRNSHolding(s) in Company
1st Sep 20257:00 amRNSTotal Voting Rights
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
ESNT
Essentra
LSE
0.00%
JPE
JPE.L
LSE
0.00%
VGAS
VGAS.L
LSE
0.00%
AJB
AJ Bell
LSE
0.00%
WG.
Wood Group (J)
LSE
0.00%
Trending
GGP
Greatland Resources
LSE
0.00%
GST
GSTechnologies
LSE
0.00%
KOD
Kodal Minerals
LSE
0.00%
RRR
Red Rock Resources
LSE
0.00%
TRP
Tower Resources
LSE
0.00%